Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics.

نویسندگان

  • Gary R Bond
  • Hea-Won Kim
  • Piper S Meyer
  • P Joseph Gibson
  • Sandra Tunis
  • Jovier D Evans
  • Paul Lysaker
  • Marion L McCoy
  • Jerry Dincin
  • Haiyi Xie
چکیده

OBJECTIVE Second-generation antipsychotics may enhance the rehabilitation of individuals with schizophrenia. The authors hypothesized that clients receiving second-generation antipsychotics would use vocational rehabilitation services more effectively and would have better employment outcomes than those receiving first-generation antipsychotics. METHODS Ninety unemployed clients with schizophrenia and related disorders who were beginning a vocational rehabilitation program were followed for nine months. Three groups were defined according to the medication in use at study entry: olanzapine (N=39), risperidone (N=27), or first-generation antipsychotics only (N=24). Participants were interviewed monthly. RESULTS The olanzapine and risperidone groups did not differ on any employment outcomes. On most vocational indicators, clients receiving second-generation agents did not differ from those receiving first-generation agents. However, at nine months the second-generation group had a significantly higher rate of participation in vocational training; a trend was found toward a higher rate of paid employment. All groups showed substantial improvement in employment outcomes after entering a vocational program. CONCLUSIONS The hypothesis that second-generation antipsychotics promote better employment outcomes than first-generation antipsychotics was not upheld. However, second-generation agents appear to be associated with increased participation in vocational rehabilitation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ASHP therapeutic position statement on the use of second-generation antipsychotic medications in the treatment of adults with psychotic disorders.

The American Society of Health-System Pharmacists (ASHP) recognizes that schizophrenia, schizoaffective disorder, and other psychotic disorders are serious mental illnesses that can significantly affect an individual’s perceptual, behavioral, affective, and cognitive functions. These conditions are usually chronic and recurrent, necessitating continuous treatment over the patient’s lifetime. In...

متن کامل

The Effectiveness of a Vocational Rehabilitation Program on the Psychological Capital in People with Spinal Cord Injury

Introduction: Vocational rehabilitation is one of the vital aspects of rehabilitation that contributes to enhancing individual, social and economic independence in daily life by increasing efficiency and restoring abilities and minimizing disabilities and achieving a capable individual. Being able to satisfy his or her job need can also enhance psychological factors. The purpose of this study w...

متن کامل

Antipsychotic Trials in Schizophrenia from India: A Systematic Review and Meta-analysis

Ethnic and regional variations have been found in the pharmacological treatment response. Though many efficacy studies have been conducted in India for antipsychotic treatment modalities of schizophrenia, there is a lack meta-analytic data of the existing literature from India. This study aimed to conduct a systematic review and meta-analysis of the antipsychotic treatment trials of schizophren...

متن کامل

Treatment-refractory schizophrenia

Between one-third and one-half of the individuals who meet diagnostic criteria for schizophrenia remain actively ill despite optimal pharmacological treatment. These individuals tend to progressively deteriorate in terms of social and vocational functioning despite major public and private investments in their rehabilitation. For patients who do not respond to the first prescribed antipsychotic...

متن کامل

The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial

Introduction: A number of research studies have shown that the new generation of neuroleptic medications can more effectively contribute to treating negative symptoms of schizophrenia compared with the first generation by influence cognitive functioning. The present study examined the therapeutic effectiveness of manufactured Risperidone and Haloperidol in Iran on treating the negative symptoms...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Psychiatric services

دوره 55 1  شماره 

صفحات  -

تاریخ انتشار 2004